HHLB Life Science
Financial · Biz. reg. 116-81-***** · 6 stocks
Value held (filed)$104M6 direct holdings
30-day netNo change
HLBdirect 1.17% · indirect 0.01%1.18%$37M
HLB Pharmaceuticaldirect 14.05% · indirect 0.03% · avg $10.69 (partial)14.08%$35M
HLB innoVationdirect 7.89% · indirect 1.31% · avg $9.63 +12%9.20%$35M
HLB Therapeuticsdirect 0.50% · indirect 0.34%0.84%$1.4M
- Direct0.50%
- HLB Pharmaceutical 14.05% → HLB Therapeutics 1.28%0.18%
- HLB 1.17% → HLB Therapeutics 13.64%0.16%
HLB Genexdirect 1.74% · indirect 0.73%2.47%$1.3M
HLB Pepdirect 2.78% · indirect 0.41%3.19%$926K
3 indirect-only holdings
No direct stake in the filings. It may be under 5% or filed before November 2024, so actual holdings may be larger.
Indirect stakes multiply ownership through listed companies. Stakes through unlisted companies and holdings under 5% are not filed. Values overlap through subsidiaries, so do not add them up.
